Distillation of the clinical algorithm improves prognosis by multi-task deep learning in high-risk Neuroblastoma

Gene expression and molecular pathway activation signatures of MYCN-amplified neuroblastomas

(2017) Ivan Petrov et al.   Oncotarget

Artificial neural network classifier predicts neuroblastoma patients’ outcome

(2016) Davide Cangelosi et al.   BMC BIOINFORMATICS

An 18 gene expression-based score classifier predicts the clinical outcome in stage 4 neuroblastoma

(2016) Daniela Formicola et al.   Journal of Translational Medicine

Deep learning

(2015) Yann LeCun et al.   NATURE

Comparison of RNA-seq and microarray-based models for clinical endpoint prediction

(2015) Wenqian Zhang et al.   GENOME BIOLOGY

HIF2A and IGF2 Expression Correlates in Human Neuroblastoma Cells and Normal Immature Sympathetic Neuroblasts

(2015) Sofie Mohlin et al.   NEOPLASIA

Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

(2014) A. Oberthuer et al.   CLINICAL CANCER RESEARCH

Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter™ system

(2014) Thomas P. Stricker et al.   Molecular Oncology

A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control Consortium

(2014)   NATURE BIOTECHNOLOGY

The genetic landscape of high-risk neuroblastoma

(2013) Trevor J Pugh et al.   NATURE GENETICS

A Comparison of MCC and CEN Error Measures in Multi-Class Prediction

(2012) Giuseppe Jurman et al.   PLoS One

Redefining functional MYCN gene signatures in neuroblastoma

(2012) J. M. Shohet   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification

(2012) L. J. Valentijn et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Prospective evaluation of prognostic factors uPA/PAI-1 in node-negative breast cancer: Phase III NNBC3-Europe trial (AGO, GBG, EORTC-PBG) comparing 6 × FEC versus 3 × FEC/3 × Docetaxel

(2011) Eva J Kantelhardt et al.   BMC CANCER

Multiple Persistent Ganglioneuromas Likely Arising From the Spontaneous Maturation of Metastatic Neuroblastoma

(2011) Jacob Rozmus et al.   JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene Signature

(2010) K. De Preter et al.   CLINICAL CANCER RESEARCH

Prognostic Impact of Gene Expression–Based Classification for Neuroblastoma

(2010) André Oberthuer et al.   JOURNAL OF CLINICAL ONCOLOGY

The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models

(2010)   NATURE BIOTECHNOLOGY

International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee

(2009) P F Ambros et al.   BRITISH JOURNAL OF CANCER

Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study

(2009) Joëlle Vermeulen et al.   LANCET ONCOLOGY